Potential therapeutic target for triple-negative breast cancer

被引:5
|
作者
Gilbert, Judith A.
机构
来源
LANCET ONCOLOGY | 2012年 / 13卷 / 08期
关键词
D O I
10.1016/S1470-2045(12)70298-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E330 / E330
页数:1
相关论文
共 50 条
  • [31] Therapeutic Strategies in Triple-Negative Breast Cancer
    Paradiso, Angelo
    Singer, Christian F.
    BREAST CARE, 2017, 12 (01) : 6 - 7
  • [32] Therapeutic Strategies for Triple-Negative Breast Cancer
    Tan, Antoinette R.
    Swain, Sandra M.
    CANCER JOURNAL, 2008, 14 (06): : 343 - 351
  • [33] Triple-negative breast cancer: therapeutic options
    Cleator, Susan
    Heller, Wolfgang
    Coombes, R. Charles
    LANCET ONCOLOGY, 2007, 8 (03): : 235 - 244
  • [34] Increased expression of folate receptor-α (FRA) in triple-negative breast cancer: A potential therapeutic target
    Crozier, Jennifer A.
    Necela, Brian M.
    Thompson, E. Aubrey
    Geiger, Xochiquetzal
    Moreno-Aspitia, Alvaro
    McCullough, Ann E.
    Pockaj, Barbara A.
    Cunliffe, Heather
    Sun, Zhifu
    Kalari, Krishna R.
    Kachergus, Jennifer M.
    O'Shannessy, Daniel J.
    Maltzman, Julia D.
    Ballman, Karla V.
    Andorfer, Cathy A.
    Perez, Edith A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Chk1 as a new therapeutic target in triple-negative breast cancer
    Albiges, Laurence
    Goubar, Aicha
    Scott, Veronique
    Vicier, Cecile
    Lefebvre, Celine
    Alsafadi, Samar
    Commo, Frederic
    Saghatchian, Mahasti
    Lazar, Vladimir
    Dessen, Philippe
    Delaloge, Suzette
    Andre, Fabrice
    Quidville, Virginie
    BREAST, 2014, 23 (03): : 250 - 258
  • [36] Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER RESEARCH, 2021, 81 (04)
  • [37] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    CANCER RESEARCH, 2020, 80 (16)
  • [38] PIM1 MAY BE A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    不详
    CANCER DISCOVERY, 2016, 6 (12) : 1303 - 1303
  • [39] Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER DISCOVERY, 2020, 10 (11) : 1706 - 1721
  • [40] SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    Kashiwagi, S.
    Yashiro, M.
    Aomatsu, N.
    Kawajiri, H.
    Takashima, T.
    Onoda, N.
    Ishikawa, T.
    Hirakawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 84 - 84